no code implementations • 19 May 2017 • Laetitia Le, Camille Marini, Alexandre Gramfort, David Nguyen, Mehdi Cherti, Sana Tfaili, Ali Tfayli, Arlette Baillet-Guffroy, Patrice Prognon, Pierre Chaminade, Eric Caudron, Balázs Kégl
Monoclonal antibodies constitute one of the most important strategies to treat patients suffering from cancers such as hematological malignancies and solid tumors.